Kimberly M. Shea, Ph.D., M.P.H.

Value and Evidence Lead
Pfizer Inc.

Disclosure(s): Pfizer: Employee, Stocks/Bonds

Poster(s):

• 106 - High Maternal Tdap Vaccine Uptake During Early Part of Vaccination Window: Implications for Future Maternal Vaccines
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 2207 - Rates of Lower Respiratory Tract Infections Among US Adults Aged ≥18 Years With and Without Chronic Medical Conditions
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET